The Effect of Motivational Interviewing on HPV-DNA Testing
The Effect of Health Belief Model-Based Motivational Interviews on Women's HPV-DNA Testing According to the Precautionary Acceptance Process
1 other identifier
interventional
90
1 country
1
Brief Summary
The aim of this randomized controlled study was to examine the effects of Health Belief Model Based Motivational Interviewing on HPV-DNA testing in women according to the Precautionary Acceptance Process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedStudy Start
First participant enrolled
February 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2025
CompletedFebruary 3, 2026
January 1, 2026
4 months
October 23, 2024
January 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Learning about HPV
The program was planned as 4 sessions and the duration of the interview was 20-30 minutes. The women in the experimental group will be given 4 motivational interviews and a training brochure. Questionnaire/scale forms will be administered 4 times in total: The scales will be administered as a pre-test before the intervention, an interim test after the second motivational interview, a final test after the fourth motivational interview, and a final test two months after the last interview. The total score to be obtained from HPV-BÖ is between 0-33 and a high score indicates a high level of knowledge about HPV, HPV screening tests and the HPV vaccine The "Cervical Cancer and Pap-smear Test Health Belief Model Scale" will be used to understand the situations that prevent women from taking the HPV-DNA test.
From the beginning of the study until the 4th month.
Secondary Outcomes (1)
Having an HPV-DNA test
From the beginning of the study until the 4th month.
Study Arms (2)
Experimental group
ACTIVE COMPARATORParticipants in the experimental group will be given motivational interviews about HPV at 4 different times and will also be given an educational brochure.
control group
NO INTERVENTIONParticipants in the control group will not receive any intervention
Interventions
No application will be made to the participants in the control group
Eligibility Criteria
You may qualify if:
- Women aged 30-45 registered at Family Health Centre No. 1,
- Who currently have or have had an active sex life,
- Women who have not undergone an HPV-DNA test in the last five years,
- Women who can read and write, have no communication problems, and can use a smartphone and WhatsApp,
- Women with no diagnosed psychiatric problems,
- Women who agreed to participate in the study.
You may not qualify if:
- Women who were unable to complete the entire study due to any circumstances during the data collection phases,
- Women who voluntarily withdrew from the study were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Muazez küçükkayalead
Study Sites (1)
Bayrampaşa 1 nolu ASM
Istanbul, BAYRAMPAŞA, 340000, Turkey (Türkiye)
Related Publications (2)
Lewandowska AM, Lewandowski T, Rudzki M, Rudzki S, Laskowska B. Cancer prevention - review paper. Ann Agric Environ Med. 2021 Mar 18;28(1):11-19. doi: 10.26444/aaem/116906. Epub 2020 Mar 12.
PMID: 33775063RESULTGhasemi M, Savabi-Esfahani M, Noroozi M, Satari M. Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model. BMC Cancer. 2024 Mar 19;24(1):351. doi: 10.1186/s12885-024-12098-9.
PMID: 38504202RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muazez Küçükkaya
Istanbul University - Cerrahpasa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 23, 2024
First Posted
October 28, 2024
Study Start
February 12, 2025
Primary Completion
June 12, 2025
Study Completion
June 12, 2025
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
I do not want to share the data due to the ethical principles of the research.